Related Experiment Video
Updated: Jul 13, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Enhancing Nix-dependent mitophagy relieves AKI by restricting TREM-1-mediated hyperactivation of inflammasome in
1College of Pulmonary and Critical Care Medicine, 8th Medical Center, Chinese PLA General Hospital, Beijing, China.
Abstract:
Platelets are highly involved in inflammation and organ injury under pathological conditions. The mitophagy in platelets may restrict hyperactivation of the inflammasome and relieve acute kidney injury (AKI). Cecal ligation puncture (CLP)/LPS-induced AKI Triggering receptor expressed on myeloid cells (TREM-1)-knockout mice models were established. Additionally, septic patients with AKI were also included. TREM-1 expression in platelets and inflammasome activation were examined. Platelet transfer assays were performed to investigate the contribution of platelet TREM-1 to renal injury. Mitophagy was evaluated in the context of inflammation. BNIP3L/Nix knockout mice were used to examine the relationship between platelet mitophagy and inflammatory activation. The results showed that the level of TREM-1 was increased and the platelet inflammasome was hyperactivated in CLP mice and septic patients, and TREM-1 activated platelet inflammasomes. TREM-1 deletion significantly abrogated hyperactivation of the platelet inflammasome and dramatically reduced AKI, whereas ablation of the mitophagy receptor BNIP3L/Nix induced the accumulation of damaged mitochondria and hyperactivation of platelet inflammasomes in CLP mice. BNIP3L/Nix controlled platelet inflammasome activation, and an amplification loop of platelet inflammasome activation and dysfunctional mitochondria controlled sepsis-related AKI. Therefore, targeting TREM-1 and NLRP3/BNIP3L in platelets may represent a novel therapeutic strategy for treating septic AKI.
Insights
Platelet mitophagy restricts inflammasome activation, protecting against sepsis-induced acute kidney injury (AKI). Targeting TREM-1 and BNIP3L in platelets offers a novel therapeutic strategy for septic AKI.
Area of Science:
- Immunology
- Pathology
- Renal Medicine
Background:
- Platelets play a crucial role in inflammation and organ injury.
- Mitophagy in platelets may mitigate inflammasome overactivation and reduce acute kidney injury (AKI).
Purpose of the Study:
- To investigate the role of Triggering receptor expressed on myeloid cells (TREM-1) and mitophagy in platelet-mediated septic AKI.
- To explore the therapeutic potential of targeting platelet TREM-1 and mitophagy pathways.
Main Methods:
- Established cecal ligation puncture (CLP)/LPS-induced AKI and TREM-1 knockout mice models.
- Included septic patients with AKI for analysis.
- Performed platelet transfer assays and evaluated mitophagy and inflammasome activation.
Main Results:
- Increased TREM-1 expression and inflammasome hyperactivation were observed in platelets from CLP mice and septic patients.
- TREM-1 deletion significantly reduced AKI and inflammasome hyperactivation.
- Ablation of mitophagy receptor BNIP3L/Nix led to damaged mitochondria accumulation and platelet inflammasome hyperactivation.
Conclusions:
- TREM-1 activates platelet inflammasomes, contributing to sepsis-related AKI.
- Dysfunctional mitophagy and platelet inflammasome activation form an amplification loop driving AKI.
- Targeting platelet TREM-1 and NLRP3/BNIP3L presents a potential therapeutic approach for septic AKI.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Nephrotic Syndrome I : Introduction
Acute Kidney Injury V: Interprofessional Care

